e-learning
resources
Barcelona 2013
Monday, 09.09.2013
A metabolic medley: sleep disordered breathing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients
V. Bironneau, E. Antone, P. Ingrand, J. Paquereau, J. C. Meurice (Poitiers, France)
Source:
Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Session:
A metabolic medley: sleep disordered breathing
Session type:
Thematic Poster Session
Number:
2540
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Bironneau, E. Antone, P. Ingrand, J. Paquereau, J. C. Meurice (Poitiers, France). Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients. Eur Respir J 2013; 42: Suppl. 57, 2540
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Prevalence of metabolic syndrome (MS) in a population of apneic patients:
A prospective study with cardiovascular risk estimation
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
Elevated risk of motor vehicle accidents in patients with obstructive sleep apnea syndrome: A case-control study
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013
Timely association between obstructive sleep apnea (OSA) and cardiovascular outcome after first acute myocardial infarction (AMI): A national wide population-based study
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016
Prevalence of obstructive sleep apnea syndrome in patients with risk factors for cardiovascular diseases in a large population in Zaragoza (Spain)
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
The clinical presentation of obstructive sleep apnea syndrome is different in diabetic patients
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016
Prevalence of metabolic syndrome with obstructive sleep apnea in a Korean population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
Sleep disordered breathing in patients with cardiovascular comorbidities hospitalized for pulmonary disease
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015
Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment
Source: Eur Respir J 2002; 20: 1511-1518
Year: 2002
Severe obstructive sleep apnea syndrome in elderly population: A prospective study of 80 patients
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015
Gout increases the risk of coronary heart disease among patients with obstructive sleep apnea: A nationwide population-based cohort study
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015
Adaptive servoventilation (ASV) decreases unplanned hospitalisations in chronic heart failure (CHF) patients with central sleep apnoea (CSA): The French multicentre, prospective FACE cohort study
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015
Frequency and predictors of obesity hypoventilation syndrome in morbidly obese (BMI ≥40) patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013
Predictors of nocturnal hypertension in obstructive sleep apnea patients with metabolic syndrome
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Protective cardiovascular effect of sleep apnea severity in obesity hypoventilation syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016
Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
Prevalence of restless legs syndrome among patients with obstructive sleep apnea before and after CPAP treatment, compared to the general population. The Icelandic Sleep Apnea Cohort (ISAC)
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
COPD and OSA: Can the overlap syndrome be suspected by clinical symptoms
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016
LATE-BREAKING ABSTRACT: The Sleep Apnea cardioVascular Endpoints (SAVE) study results – A trial of CPAP versus usual care in 2717 high cardiovascular risk patients with moderate-severe obstructive sleep apnea (OSA)
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016
Dietary treatment outcomes of mild obstructive sleep apnea in obese community-dwelling children: The NANOS study
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015
Obesity and chronic intermittent hypoxia are independent risk factors for clinical decompensation in patients with cirrhosis and OSAS
Source: International Congress 2014 – Inflammation and obesity: implications for OSA
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept